Collagen impairs glucocorticoid actions in airway smooth muscle through integrin signalling

British Journal of Pharmacology

Volumn 149, Issue 4, 2006, Pages 365-373

  Bonacci, J V ^a   Schuliga, M ^a   Harris, T ^a   Stewart, A G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Asthma; COPD; Extracellular matrix; Glucocorticoid resistance; Laminin; Smooth muscle; Steroids

Indexed keywords

ANTIMITOTIC AGENT; COLLAGEN; CYCLIN D1; DEXAMETHASONE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; INTEGRIN; LAMININ; MONOMER; PENTAPEPTIDE; SCLEROPROTEIN; TYROSYLISOLEUCYLGLYCYLSERYLARGININE; VERY LATE ACTIVATION ANTIGEN 2;

ARTICLE; ASTHMA; BREATHING MUSCLE; CELL MIGRATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG MECHANISM; FIBROSIS; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE; TREATMENT RESPONSE;

ANDROSTADIENES; BRONCHI; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; CYCLIN D; CYCLINS; DEXAMETHASONE; DRUG RESISTANCE; GLUCOCORTICOIDS; HUMANS; INTEGRIN ALPHA2BETA1; LAMININ; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION;

EID: 33750043230     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706881     Document Type: Article

References (36)

1. Barnes PJ (2004). New drugs for asthma. Nat Rev Drug Discov 3: 831-844.
2. Barnes PJ, Adcock IM (2003). How do corticosteroids work in asthma? Ann Intern Med 139: 359-370.
3. Bonacci JV, Harris T, Wilson JW, Stewart AG (2003). Collagen-induced resistance to glucocorticoid anti-mitogenic actions: a potential explanation of smooth muscle hyperplasia in the asthmatic remodelled airway. Br J Pharmacol 138: 1203-1206.
4. Bonacci JV, Stewart AG (2006). Regulation of human airway mesenchymal cell proliferation by glucocorticoids and beta(2)-adrenoceptor agonists. Pulm Pharmacol Ther 19: 32-38.
5. Boulet LP (2003). Physiopathology of airway hyperresponsiveness. Curr Allergy Asthma Rep 3: 166-171.
6. Bramley AM, Roberts CR, Schellenberg RR (1995). Collagenase increases shortening of human bronchial smooth muscle in vitro. Am J Respir Crit Care Med 152: 1513-1517.
7. Carroll N, Elliot J, Morton A, James A (1993). The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 147: 405-410.
8. D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B et al. (2000). The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275: 32649-32657.
9. Ebina M, Takahashi T, Chiba T, Motomiya M (1993). Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma: a 3-D morphometric study. Am Rev Respir Dis 148: 720-726.
10. Fernandes D, Guida E, Koutsoubos V, Harris T, Vadiveloo P, Wilson JW et al. (1999). Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol 21: 77-88.
11. Freyer AM, Johnson SR, Hall IP (2001). Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells. Am J Respir Cell Mol Biol 25: 569-576.
12. Gizycki MJ, Adelroth E, Rogers AV, O'Byrne PM, Jeffery PK (1997). Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 16: 664-673.
13. Goncharova EA, Ammit AJ, Irani C, Carroll RG, Eszterhas AJ, Panettieri RA et al. (2002). PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 283: L354-L363.
14. Goncharova EA, Billington CK, Irani C, Vorotnikov AV, Tkachuk VA, Penn RB et al. (2003). Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration. Am J Respir Cell Mol Biol 29: 19-27.
15. Hirst SJ, Martin JG, Bonacci JV, Chan V, Fixman ED, Hamid QA et al. (2004). Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol 114: S2-S17.
16. Hirst SJ, Twort CH, Lee TH (2000). Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. Am J Respir Cell Mol Biol 23: 335-344.
17. James A, Carroll N (2000). Airway smooth muscle in health and disease; methods of measurement and relation to function. Eur Respir J 15: 782-789.
18. Johnson PR, Black JL, Carlin S, Ge Q, Underwood PA (2000). The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture: the effect of beclomethasone. Am J Respir Crit Care Med 162: 2145-2151.
19. Johnson PR, Roth M, Tamm M, Hughes M, Ge Q, King G et al. (2001). Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 164: 474-477.
20. Kraft M, Lewis C, Pham D, Chu HW (2001). IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma. J Allergy Clin Immunol 107: 602-606.
21. Mast A, Bamford TL, Wilson JW, Pain MC, Robertson CF, Smallwood D et al. (2003). Smooth muscle area is increased in bronchial biopsies from steroid-resistant asthma. Am J Respir Crit Care Med 167: A33.
22. Nguyen TT, Ward JP, Hirst SJ (2005). beta1-Integrins mediate enhancement of airway smooth muscle proliferation by collagen and fibronectin. Am J Respir Crit Care Med 171: 217-223.
23. Ohbayashi H (2002). Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 3: 409-421.
24. Parameswaran K, Radford K, Zuo J, Janssen LJ, O'Byrne PM, Cox PG (2004). Extracellular matrix regulates human airway smooth muscle cell migration. Eur Respir J 24: 545-551.
25. Redington AE (2000). Airway fibrosis in asthma: mechanisms, consequences, and potential for therapeutic intervention. Monaldi Arch Chest Dis 55: 317-323.
26. Scaffidi AK, Moodley YP, Weichselbaum M, Thompson PJ, Knight DA (2001). Regulation of human lung fibroblast phenotype and function by vitronectin and vitronectin integrins. J Cell Sci 114: 3507-3516.
27. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S (2003). Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 171: 380-389.
28. Stewart AG (2001). Airway smooth muscle as a target for novel anti-asthma drugs acting on airway wall remodelling. In: Howarth P, Wilson JW, Bousquet J, Rak S, Pauwels RA (eds) Airway Wall Remodeling. Marcel Dekker Inc.: New York, pp 217-243.
29. Stewart AG (2004). Emigration and immigration of mesenchymal cells: a multicultural airway wall. Eur Respir J 24: 515-517.
30. Stewart AG, Bonacci JV, Quan L (2004). Factors controlling airway smooth muscle proliferation in asthma. Curr Allergy Asthma Rep 4: 109-115.
31. Stewart AG, Fernandes D, Tomlinson PR (1995). The effect of glucocorticoids on proliferation of human cultured airway smooth muscle. Br J Pharmacol 116: 3219-3226.
32. Stewart AG, Tomlinson PR, Wilson J (1993). Airway wall remodelling in asthma: a novel target for the development of anti-asthma drugs. Trends Pharmacol Sci 14: 275-279.
33. Tran T, Fernandes DJ, Schuliga M, Harris T, Landells L, Stewart AG (2005). Stimulus-dependent glucocorticoid-resistance of GM-CSF production in human cultured airway smooth muscle. Br J Pharmacol 145: 123-131.
34. Vlahos R, Lee KS, Guida E, Fernandes DJ, Wilson JW, Stewart AG (2003). Differential inhibition of thrombin- and EGF-stimulated human cultured airway smooth muscle proliferation by glucocorticoids. Pulm Pharmacol Ther 16: 171-180.
35. Yamamoto K, Yamamoto M (1994). Cell adhesion receptors for native and denatured type I collagens and fibronectin in rabbit arterial smooth muscle cells in culture. Exp Cell Res 214: 258-263.
36. Zhao J, Pestell R, Guan JL (2001). Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. Mol Biol Cell 12: 4066-4077.